Pharmaceuticals manufacturer and distributor AmerisourceBergen Corp. has changed its name to Cencora.
Under the new name Cencora, the company unifies its 46,000 employees – across several global business segments – under one identity, company officials said in an Aug. 30 news release. The company had approximately $239 billion in fiscal 2022 revenue.
As a global healthcare company, Cencora will continue to invest in and focus on its core pharmaceutical distribution business, while also growing its platform of pharma and biopharma services to support pharmaceutical innovation and access across the globe.
AmerisourceBergen Foundation Becomes Cencora Impact Foundation
Cencora announced a $5 million donation to the Cencora Impact Foundation, formerly known as the AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization.
The donation will be used to launch the Cencora Healthier Futures Grant Program, which aims to identify opportunities to support those on the front lines of healthcare in underserved populations who are driving innovation in global health. Targeted donations from the Cencora Healthier Futures Grant Program, operated by Cencora Impact Foundation, will go toward nonprofits and charities around the world that are advancing access to care and directly impacting communities in need.
Cencora Ventures, formerly known as AB Health Ventures, the company’s dedicated corporate venture fund, has also committed to donating 10% of future realized profits to support the efforts of the Cencora Impact Foundation and its continued work to improve healthcare access globally.